glp-1 for addiction treatment The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders GLP-1 Medication Supported for Addiction

A 2010 study by Tudor and colleagues in Regulatory Peptides reported that BPC-157 at 10 g/kg or 10 ng/kg i.p., given 30 minutes before falling-weight traumatic brain injury in mice, directionally reduced unconsciousness and mortality across force impulses of 0.0680.145 Ns, with the higher dose effective at the maximum 0.159 Ns impulse though the abstract does not report numeric mortality percentages or p-values

Novel adjuvant therapies for type 1 diabetes have remained elusive

Book your consultation here

For Gynecology Individuals exposed to heavy metals, experiencing chronic fatigue, or seeking to enhance their overall wellness may benefit

In the ever-evolving field of longevity science, Epithalon represents just one of many powerful, healing peptides we can leverage to restore, maintain, and optimize healthspan and lifespan

Like so many women, the early stages of perimenopause were sending everything from Anderson's hunger cues to her energy levels and mental clarity haywire